Search company, investor...

Predict your next investment

Venture Capital
6dimensionscapital.com

Investments

55

Portfolio Exits

14

Funds

4

Partners & Customers

2

About 6 Dimensions Capital

6 Dimensions Capital, formed from the merger of Frontline BioVentures and WuXi Healthcare Ventures, is a healthcare-focused investment firm.

Headquarters Location

Suite 1106, Building A, SCG Parkside, 868 Lane, Yinghua Road Pudong New District

Shanghai, Shanghai, 201204,

China

+86 (021) 5046-2227

Want to inform investors similar to 6 Dimensions Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

6 Dimensions Capital Investments

55 Investments

6 Dimensions Capital has made 55 investments. Their latest investment was in Tongyi Medicine as part of their Series B on August 8, 2022.

CBI Logo

6 Dimensions Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/2/2022

Series B

Tongyi Medicine

No

1

12/9/2021

Series B

Halda Therapeutics

$51M

Yes

4

11/11/2021

Series A

Ignis Therapeutics

$180M

Yes

9

11/1/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

10/5/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/2/2022

12/9/2021

11/11/2021

11/1/2021

10/5/2021

Round

Series B

Series B

Series A

Series B

Series B

Company

Tongyi Medicine

Halda Therapeutics

Ignis Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$51M

$180M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

9

10

10

6 Dimensions Capital Portfolio Exits

14 Portfolio Exits

6 Dimensions Capital has 14 portfolio exits. Their latest portfolio exit was GRAIL on August 18, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/18/2021

Acquired

$99M

36

7/16/2021

IPO

$99M

Public

6

7/13/2021

IPO

$99M

Public

4

8/21/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

7/24/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/18/2021

7/16/2021

7/13/2021

8/21/2020

7/24/2020

Exit

Acquired

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

36

6

4

10

10

6 Dimensions Capital Acquisitions

3 Acquisitions

6 Dimensions Capital acquired 3 companies. Their latest acquisition was Gloria Biotech on August 17, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/17/2018

$99M

Corporate Majority

2

5/18/2017

Subscribe to see more

$99M

Subscribe to see more

10

5/18/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/17/2018

5/18/2017

5/18/2017

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Corporate Majority

Subscribe to see more

Subscribe to see more

Sources

2

10

10

6 Dimensions Capital Fund History

4 Fund Histories

6 Dimensions Capital has 4 funds, including 6 Dimensions Capital.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/7/2017

6 Dimensions Capital

Diversified Private Equity

Closed

1

12/7/2017

6 Dimensions Capital RMB LP

Subscribe to see more

Subscribe to see more

$99M

10

6 Dimensions Capital Fund I

10

6 Dimensions Affiliates Fund

10

Closing Date

12/7/2017

12/7/2017

Fund

6 Dimensions Capital

6 Dimensions Capital RMB LP

6 Dimensions Capital Fund I

6 Dimensions Affiliates Fund

Fund Type

Diversified Private Equity

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$99M

Sources

1

10

10

10

6 Dimensions Capital Partners & Customers

2 Partners and customers

6 Dimensions Capital has 2 strategic partners and customers. 6 Dimensions Capital recently partnered with Menlo Therapeutics on April 4, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

4/23/2020

Licensor

United States

Menlo Therapeutics and Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™ and Approved Topical Minocycline Products in Greater China

BRIDGEWATER , N.J. , April 23 , 2020 -- Menlo Therapeutics Inc. , a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology , today announced that its wholly-owned subsidiary , Foamix Pharmaceuticals Ltd. , has entered into a licensing agreement with specialty pharmaceutical company Cutia Therapeutics Limited , an affiliate of Cutia Therapeutics for AMZEEQ ™ topical foam , 4 % as well as its other topical minocycline product candidates , once approved , on an exclusive basis in Greater China .

2

4/23/2020

Licensor

Israel

Subscribe to see more

Subscribe to see more

10

Date

4/23/2020

4/23/2020

Type

Licensor

Licensor

Business Partner

Country

United States

Israel

News Snippet

Menlo Therapeutics and Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™ and Approved Topical Minocycline Products in Greater China

BRIDGEWATER , N.J. , April 23 , 2020 -- Menlo Therapeutics Inc. , a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology , today announced that its wholly-owned subsidiary , Foamix Pharmaceuticals Ltd. , has entered into a licensing agreement with specialty pharmaceutical company Cutia Therapeutics Limited , an affiliate of Cutia Therapeutics for AMZEEQ ™ topical foam , 4 % as well as its other topical minocycline product candidates , once approved , on an exclusive basis in Greater China .

Subscribe to see more

Subscribe to see more

Sources

2

10

6 Dimensions Capital Team

6 Team Members

6 Dimensions Capital has 6 team members, including current Chief Executive Officer, Leon Chen.

Name

Work History

Title

Status

Leon Chen

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Leon Chen

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.